SARS-CoV-2 ORF8 Mediates Signals in Macrophages and Monocytes through MyD88 Independently of the IL-17 Receptor
The Journal of Immunology · 15.07.2023 · 211 (2) · 252-260
DOI: 10.4049/jimmunol.2300110 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Immunology, online erschienen am 02.06.2023. Verfasst von Nicole O Ponde und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Rheumatology and Clinical Immunology, Department of Medicine, University of Pittsburgh, Pittsburgh, PA. Hauptthemen laut MEDLINE: COVID-19, Open Reading Frames, SARS-CoV-2. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIAID NIH HHS, NIAMS NIH HHS.
Abstract (Originalsprache)
SARS-CoV-2 has caused an estimated 7 million deaths worldwide to date. A secreted SARS-CoV-2 accessory protein, known as open reading frame 8 (ORF8), elicits inflammatory pulmonary cytokine responses and is associated with disease severity in COVID-19 patients. Recent reports proposed that ORF8 mediates downstream signals in macrophages and monocytes through the IL-17 receptor complex (IL-17RA, IL-17RC). However, generally IL-17 signals are found to be restricted to the nonhematopoietic compartment, thought to be due to rate-limiting expression of IL-17RC. Accordingly, we revisited the capacity of IL-17 and ORF8 to induce cytokine gene expression in mouse and human macrophages and monocytes. In SARS-CoV-2–infected human and mouse lungs, IL17RC mRNA was undetectable in monocyte/macrophage populations. In cultured mouse and human monocytes and macrophages, ORF8 but not IL-17 led to elevated expression of target cytokines. ORF8-induced signaling was fully preserved in the presence of anti–IL-17RA/RC neutralizing Abs and in Il17ra−/− cells. ORF8 signaling was also operative in Il1r1−/− bone marrow–derived macrophages. However, the TLR/IL-1R family adaptor MyD88, which is dispensable for IL-17R signaling, was required for ORF8 activity yet MyD88 is not required for IL-17 signaling. Thus, we conclude that ORF8 transduces inflammatory signaling in monocytes and macrophages via MyD88 independently of the IL-17R.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Rheumatology and Clinical Immunology, Department of Medicine, University of Pittsburgh, Pittsburgh, PA.
- Department of Immunology, University of Pittsburgh, Pittsburgh, PA.
- Tulane University, New Orleans, LA.
- Department of Dermatology, University of Michigan, Ann Arbor, MI.
ORCID-Profile: Nicole O Ponde, Mrinal K Sarkar, Tiffany C Taylor, Rylee N Cisney, Samyuktha P Arunkumar, Johann E Gudjonsson, Jay K Kolls, Rachel A Gottschalk, Sarah L Gaffen
Förderung
- NHLBI NIH HHS
- NIAID NIH HHS
- NIAMS NIH HHS
- NIGMS NIH HHS
- HHS | NIH | National Institute of Allergy and Infectious Diseases
- HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases
- National Psoriasis Foundation
- HHS | NIH | National Institute of General Medical Sciences
Zitieren
APA
Ponde, N. O., Shoger, K. E., Khatun, M. S., Sarkar, M. K., Dey, I., Taylor, T. C., Cisney, R. N., Arunkumar, S. P., Gudjonsson, J. E., Kolls, J. K., Gottschalk, R. A., & Gaffen, S. L. (2023). SARS-CoV-2 ORF8 Mediates Signals in Macrophages and Monocytes through MyD88 Independently of the IL-17 Receptor. The Journal of Immunology, 211(2), 252-260. https://doi.org/10.4049/jimmunol.2300110
Vancouver
Ponde NO, Shoger KE, Khatun MS, Sarkar MK, Dey I, Taylor TC, et al. SARS-CoV-2 ORF8 Mediates Signals in Macrophages and Monocytes through MyD88 Independently of the IL-17 Receptor. The Journal of Immunology. 2023;211(2):252-260. doi:10.4049/jimmunol.2300110
BibTeX
@article{Ponde2023,
author = {Ponde, Nicole O and Shoger, Karsen E and Khatun, Mst Shamima and Sarkar, Mrinal K and Dey, Ipsita and Taylor, Tiffany C and Cisney, Rylee N and Arunkumar, Samyuktha P and Gudjonsson, Johann E and Kolls, Jay K and Gottschalk, Rachel A and Gaffen, Sarah L},
title = {SARS-CoV-2 ORF8 Mediates Signals in Macrophages and Monocytes through MyD88 Independently of the IL-17 Receptor},
journal = {The Journal of Immunology},
year = {2023},
volume = {211},
number = {2},
pages = {252--260},
doi = {10.4049/jimmunol.2300110}
}
EUVIMED